L Landherr-Laszlo

Uzsoki Street Hospital
Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

5th Hungarian Breast Cancer Consensus Conference - radiotherapy guidelines

5th Hungarian Breast Cancer Consensus Conference - radiotherapy guidelines

Journal: Magyar onkologia

Published: June 16, 2025

Radiotherapy of Breast Cancer-Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Radiotherapy of Breast Cancer-Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Journal: Pathology oncology research : POR

Published: February 19, 2022

Title Not Found

Title Not Found

Journal: Magyar onkologia

Published: February 04, 2022

Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.

Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.

Journal: Pathology oncology research : POR

Published: February 19, 2021

Secondary lung cancer risk after breast cancer radiation therapy. The benefits substantially overweight the minimal disadvantages

Secondary lung cancer risk after breast cancer radiation therapy. The benefits substantially overweight the minimal disadvantages

Journal: Magyar onkologia

Published: October 18, 2020

4th Hungarian Breast Cancer Consensus Conference - Radiotherapy guidelines

4th Hungarian Breast Cancer Consensus Conference - Radiotherapy guidelines

Journal: Magyar onkologia

Published: September 30, 2020

Complex treatment of colorectal liver metastases Consensus Conference, Budapest, 5th April 2019

Complex treatment of colorectal liver metastases Consensus Conference, Budapest, 5th April 2019

Journal: Orvosi hetilap

Published: October 01, 2019

Oral contraception and the risk of breast cancer. Review of the literature

Oral contraception and the risk of breast cancer. Review of the literature

Journal: Magyar onkologia

Published: July 10, 2018

Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial.

Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial.

Journal: JAMA oncology

Published: June 05, 2018

Alcohol and breast cancer. A short survey

Alcohol and breast cancer. A short survey

Journal: Magyar onkologia

Published: January 16, 2018

An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.

An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.

Journal: Cancer medicine

Published: October 20, 2017

The post-treatment cognitive impairment ("chemobrain") in breast cancer patients. Short review.

The post-treatment cognitive impairment ("chemobrain") in breast cancer patients. Short review.

Journal: Magyar onkologia

Published: July 14, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026